Rznomics Partners with Eli Lilly for RNA-editing Therapeutics Licensing
Co-development of precision RNA therapeutics for inherited hearing loss treatment Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics, announced today that it has...